Company Search:
Advanced Search
Sponsored Links
Medite Cancer Diagnostics Inc Company Snapshot
Medite Cancer Diagnostics Inc operates in the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medite Cancer Diagnostics Inc with three other companies in this sector in UNITED STATES : Transenterix Inc (2017 sales of $7.11 million of which 100% was Medical Device), Senseonics Holdings Inc ($6.37 million of which 100% was Glucose Monitoring Systems), and Plus Therapeutics Inc ($6.41 million ).

Sales Analysis. Medite Cancer Diagnostics Inc reported sales of $6.81 million for the year ending December of 2017. This represents a sharp decrease of 26.3% versus 2016, when the company's sales were $9.24 million.
  Stock Performance Chart for Medite Cancer Diagnostics Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): .00
(Figures in U.S. Dollars)
1 Week 32.3%   13 Weeks -70.5%  
4 Weeks -93.0%   52 Weeks n/a  
Medite Cancer Diagnostics Inc Key Data:
  Ticker: MDIT Country: United States
  Exchanges: FRA OTC Major Industry: Health Care Equipment & Services
    Sub Industry: Surgical & Medical Instruments
  2017 Sales 6,813,000
(Year Ending Jan 2018).
Employees: 6
  Currency: U.S. Dollars Market Cap: 355,567
  Fiscal Yr Ends: December Shares Outstanding: 86,723,700
  Share Type: Common Closely Held Shares: 57,714,682
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.